Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trialDaniel S. Reich, Sibyl Wray, Robert J. Fox et al.|The Lancet Neurology|2021Cited by 192
Teriflunomide added to interferon-β in relapsing multiple sclerosisM. S. Freedman, K. Ton, Jerry S. Wolinsky et al.|Neurology|2012Cited by 78